Nivoix, Sophie; Nguyen, Pascal - In: Asia Pacific Business Review 18 (2012) 2, pp. 225-240
Characterized by a high level of R&D expenditure, pharmaceutical firms are also subject to specific risks that are reflected in their financial policies. In contrast to other firms, whose investments are directly related to internal cash flows, Japanese pharmaceutical companies do not appear to...